These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 27378570)
1. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137. Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570 [TBL] [Abstract][Full Text] [Related]
2. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion. Salie R; Alsalhin AKH; Marais E; Lochner A Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348 [TBL] [Abstract][Full Text] [Related]
3. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. Hamid SA; Bower HS; Baxter GF Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176 [TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore. Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017 [TBL] [Abstract][Full Text] [Related]
5. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030 [TBL] [Abstract][Full Text] [Related]
6. Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K/Akt/eNOS signaling. Liu Q; Li Z; Liu Y; Xiao Q; Peng X; Chen Q; Deng R; Gao Z; Yu F; Zhang Y Cardiovasc Ther; 2018 Dec; 36(6):e12481. PubMed ID: 30597772 [TBL] [Abstract][Full Text] [Related]
7. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK. Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328 [TBL] [Abstract][Full Text] [Related]
8. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice. Qiu Y; Wu Y; Meng M; Luo M; Zhao H; Sun H; Gao S J Surg Res; 2018 May; 225():29-39. PubMed ID: 29605032 [TBL] [Abstract][Full Text] [Related]
9. Cardioprotective PKG-independent NO signaling at reperfusion. Cohen MV; Yang XM; Liu Y; Solenkova NV; Downey JM Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2028-36. PubMed ID: 20852051 [TBL] [Abstract][Full Text] [Related]
10. Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats. Yang S; Abbott GW; Gao WD; Liu J; Luo C; Hu Z J Appl Physiol (1985); 2017 May; 122(5):1095-1105. PubMed ID: 28153944 [TBL] [Abstract][Full Text] [Related]
11. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats. Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199 [TBL] [Abstract][Full Text] [Related]
12. Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning. Abwainy A; Babiker F; Akhtar S; Benter IF Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H104-12. PubMed ID: 26519026 [TBL] [Abstract][Full Text] [Related]
13. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258 [TBL] [Abstract][Full Text] [Related]